☰

Rositsa B. Dimova, Ph.D. - Publications

Affiliations: 
2010 Columbia University, New York, NY 
Area:
Statistics
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Dimova RB, Rude E, Talal AH. Age and Risk-Factor Based Serologic Screening for Hepatitis C Virus among an Urban, High-Risk Population. Journal of Viral Hepatitis. PMID 32615009 DOI: 10.1111/Jvh.13359  0.517
2016 Zeremski M, Dimova RB, Pillardy J, de Jong YP, Jacobson IM, Talal AH. Fibrosis Progression in Patients with Chronic Hepatitis C Virus Infection. The Journal of Infectious Diseases. PMID 27485356 DOI: 10.1093/Infdis/Jiw332  0.566
2016 Zeremski M, Zavala R, Dimova RB, Chen Y, Kritz S, Sylvester C, Brown LS, Talal AH. Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention. Journal of Addiction Medicine. PMID 26881485 DOI: 10.1097/Adm.0000000000000196  0.485
2016 Samuel ST, Martinez AD, Munjal S, George E, Basil M, Chen Y, Dimova RB, Talal A. Knowledge of Hepatitis C Acquisition Risks is Associated with Improved Birth Cohort-Based Screening Practices among Primary Care Physicians Journal of Hepatology. 64. DOI: 10.1016/S0168-8278(16)00762-5  0.312
2015 Zeremski M, Dimova RB, Benjamin S, Penney MS, Botfield MC, Talal AH. Intrahepatic and Peripheral CXCL10 Expression in Hepatitis C Virus-Infected Patients Treated With Telaprevir, Pegylated Interferon, and Ribavirin. The Journal of Infectious Diseases. 211: 1795-9. PMID 25512630 DOI: 10.1093/Infdis/Jiu807  0.579
2015 Zeremski M, Dimova RB, Benjamin S, Penney MS, Botfield MC, Talal AH. Intrahepatic and peripheral CXCL10 expression in hepatitis C virus-infected patients treated with telaprevir, pegylated interferon, and ribavirin Journal of Infectious Diseases. 211: 1795-1799. DOI: 10.1093/infdis/jiu807  0.418
2014 Zeremski M, Dimova RB, Benjamin S, Makeyeva J, Yantiss RK, Gambarin-Gelwan M, Talal AH. FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B Bmc Gastroenterology. 14. PMID 24990385 DOI: 10.1186/1471-230X-14-118  0.438
2014 Zeremski M, Dimova RB, Zavala R, Kritz S, Lin M, Smith BD, Zibbell JE, Talal AH. Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance. Journal of Addiction Medicine. 8: 249-57. PMID 24820257 DOI: 10.1097/Adm.0000000000000041  0.55
2014 Talal AH, Dimova RB, Zhang EZ, Jiang M, Penney MS, Sullivan JC, Botfield MC, Chakilam A, Sawant R, Cervini CM, Zeremski M, Jacobson IM, Kwong AD. Telaprevir-based treatment effects on hepatitis C virus in liver and blood. Hepatology (Baltimore, Md.). 60: 1826-37. PMID 24811404 DOI: 10.1002/Hep.27202  0.535
2014 Zeremski M, Dimova RB, Zavala R, Kritz S, Lin M, Smith BD, Zibbell J, Talal AH. P1192 Hepatitis C Virus (Hcv) Related Knowledge And Willingness To Receive Treatment Among Patients On Methadone Maintenance Journal of Hepatology. 60. DOI: 10.1016/S0168-8278(14)61352-0  0.532
2013 Zeremski M, Dimova RB, Makeyeva J, Sipley JD, Jacobson IM, Rennert H, Talal AH. IL28B polymorphism, pretreatment CXCL10, and HCV RNA levels predict treatment response in racially diverse HIV/HCV coinfected and HCV monoinfected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 9-16. PMID 23274935 DOI: 10.1097/Qai.0B013E31828323C1  0.528
2013 Dimova RB, Zeremski M, Jacobson IM, Hagan H, Des Jarlais DC, Talal AH. Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 806-16. PMID 23223596 DOI: 10.1093/Cid/Cis1007  0.561
2013 Talal AH, Dimova RB, Seewald R, Peterson RH, Zeremski M, Perlman DC, Des Jarlais DC. Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. Journal of Substance Abuse Treatment. 44: 115-9. PMID 22405884 DOI: 10.1016/J.Jsat.2012.01.010  0.525
2012 Martinez AD, Dimova R, Marks KM, Beeder AB, Zeremski M, Kreek MJ, Talal AH. Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance. Journal of Viral Hepatitis. 19: 47-54. PMID 21129131 DOI: 10.1111/J.1365-2893.2010.01411.X  0.55
2011 Talal AH, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein T, Doonquah L, Aboulafia D, Rodriguez J, Bonilla H, Galpin J, Aberg JA, Johnston B, Glesby MJ, et al. Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 261-8. PMID 21876446 DOI: 10.1097/Qai.0B013E3182324Af9  0.532
2011 Zeremski M, Dimova R, Astemborski J, Thomas DL, Talal AH. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C. The Journal of Infectious Diseases. 204: 832-6. PMID 21849280 DOI: 10.1093/Infdis/Jir424  0.571
2011 Dimova RB, Markatou M, Talal AH. Information methods for model selection in linear mixed effects models with application to HCV data Computational Statistics and Data Analysis. 55: 2677-2697. DOI: 10.1016/J.Csda.2010.10.031  0.562
2010 Dimova RB, Talal AH. Pharmacokinetic and pharmacodynamic modeling of pegylated-interferon alfa. Journal of Hepatology. 53: 418-20. PMID 20561707 DOI: 10.1016/J.Jhep.2010.04.014  0.546
2009 Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, Talal AH. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. The Journal of Infectious Diseases. 200: 1774-80. PMID 19848607 DOI: 10.1086/646614  0.648
2008 Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md.). 48: 1440-50. PMID 18798334 DOI: 10.1002/Hep.22500  0.641
2006 Xu H, Markatou M, Dimova R, Liu H, Friedman C. Machine learning and word sense disambiguation in the biomedical domain: design and evaluation issues. Bmc Bioinformatics. 7: 334. PMID 16822321 DOI: 10.1186/1471-2105-7-334  0.512
Show low-probability matches.